The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of fruquintinib plus investigator's choice of chemotherapy as second-line therapy in metastatic colorectal cancer: A multicenter, single-arm phase 2 trial.
 
Wensi Zhao
No Relationships to Disclose
 
Liping Li
No Relationships to Disclose
 
Junping Huang
No Relationships to Disclose
 
Jun Li
No Relationships to Disclose
 
Wei Gong
No Relationships to Disclose
 
Lilin He
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Songlin Wang
No Relationships to Disclose
 
Xiongjie Yu
No Relationships to Disclose
 
Qi Han
No Relationships to Disclose
 
Shaobo Ke
No Relationships to Disclose
 
Wei Shi
No Relationships to Disclose
 
Yongshun Chen
No Relationships to Disclose